Oncology/Hematology

Subscribe to learn more

2024 MIPS by Specialty

2024 MIPS Measure #102: Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients

High Priority: Yes

Percentage of patients, regardless of age, with a diagnosis of prostate cancer at low (or very low) risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy who did not have a bone scan performed at any time since diagnosis of prostate cancer.

Measure Type

Specifications

SPECIALTY

2024 MIPS Measure #143: Oncology: Medical and Radiation – Pain Intensity Quantified

High Priority: Yes

Percentage of patient visits, regardless of patient age, with a diagnosis of cancer currently receiving chemotherapy or radiation therapy in which pain intensity is quantified.

Oncology/Hematology

2024 MIPS by Specialty

2024 MIPS Measure #102: Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients

Measure Type

Specifications

SPECIALTY

2024 MIPS Measure #143: Oncology: Medical and Radiation – Pain Intensity Quantified

Measure Type

SPECIALTY

Specifications

Quality Reportings

Services

Company

Email Us At :

Call us at : 6am - 10pm

Fax us at:

Location :

Site Map